STABILITY OF CEFTAZIDIME AND VANCOMYCIN ALONE AND IN COMBINATION IN HEPARINIZED AND NONHEPARINIZED PERITONEAL-DIALYSIS SOLUTION

OBJECTIVE: To examine the stability of ceftazidime, vancomycin, and he parin, alone and in combination, in dialysis solution over six days at three temperatures. DESIGN: Nine 250-mL Dianeal PD-2 dextrose 1.5% ba gs were prepared with ceftazidime, vancomycin, and heparin alone and i n combination at set concentrations of 100 mug/mL, 50 mug/mL, and 1 un it/mL, respectively. Three bags of each mixture were stored at 4, 25, and 37-degrees-C. Duplicate samples for analysis were removed from eac h bag at the following time points: premix, 0, 12, 24, 48, 72, 96, 120 , and 144 hours. MAIN OUTCOME MEASURES: Each sample was examined visua lly for signs of cloudiness and precipitation. Each sample was analyze d by stability-indicating HPLC assay for ceftazidime and vancomycin, w ith stability defined as less than 10 percent degradation of drug over time. RESULTS: No color change or precipitation was observed in any b ag. Vancomycin with or without heparin was stable for 5-6 days at 4, 2 5, and 37-degrees-C. Ceftazidime with and without heparin was stable f or 6 days at 4-degrees-C, 4 days at 25-degrees-C, and less than 12 hou rs at 37-degrees-C. Vancomycin plus ceftazidime with and without hepar in was stable for 6 days at 4-degrees-C and 25-degrees-C, and 4-5 days at 37-degrees-C. Ceftazidime plus vancomycin with or without heparin was stable for 6 days at 4-degrees-C, 2-3 days at 25-degrees-C, and 12 hours at 37-degrees-C. CONCLUSIONS: Bulk preparations of ceftazidime and vancomycin, alone and in combination and with or without heparin i n Dianeal PD dextrose 1.5% solution, are sufficiently stable for use u p to 6 days under refrigeration or 48 hours at room temperature.